Early treatment study
et al., Eur. Rev. Med. Pharmacol. Sci. 2020, 24 (8), 4539-4547, doi:10.26355/eurrev_202004_21038 (Peer Reviewed)
Efficacy of ch loroquine and hydroxych loroquine in the treatment of COVID-19
Analysis of COVID-19 and malaria, finding that COVID-19 is highly pandemic in countries where malaria is least pandemic, and vice versa, suggesting that C Q/HC Q (widely used for malaria) are protective for COVID-19. This paper also includes a review of 9 articles supporting the efficacy of HC Q and C Q.
Please send us corrections, updates, or comments.